Analysts expect Acumen Pharmaceuticals, Inc. to report revenue of 0.00 for Q3 26, against a range of 0.00 to 0.00. The most recent reported quarter, Q2 26, came in at 0.00.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 908,876.20 | 1.01 M | ||||||||||
| Low Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 794,004.94 | 872,023.48 | ||||||||||
| Consensus Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 851,440.57 | 940,709.38 |
Analysts expect Acumen Pharmaceuticals, Inc. to report earnings per share of -0.40 for Q3 26, against a range of -0.43 to -0.37. The most recent reported quarter, Q2 26, came in at -0.45, a 28.6% miss against the -0.35 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.50 | -0.62 | -0.48 | -0.68 | -0.44 | -0.40 | -0.33 | -0.45 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.34 | -0.50 | -0.70 | -0.47 | -0.56 | -0.43 | -0.38 | -0.32 | -0.37 | -0.31 | -0.27 | -0.30 | -0.25 | -0.27 | -0.29 | -0.29 | ||||||||||
| Low Estimate | -0.36 | -0.58 | -0.82 | -0.57 | -0.68 | -0.49 | -0.46 | -0.38 | -0.43 | -0.37 | -0.29 | -0.32 | -0.29 | -0.31 | -0.35 | -0.33 | ||||||||||
| Consensus Estimate | -0.35 | -0.54 | -0.76 | -0.52 | -0.62 | -0.46 | -0.42 | -0.35 | -0.40 | -0.34 | -0.28 | -0.31 | -0.27 | -0.29 | -0.32 | -0.31 |